SKYSTAR BIO-PHARMACEUTICAL CO Selling Expense
SKYSTAR BIO-PHARMACEUTICAL CO reported Selling Expense of $1.08 million for the 3-month period ending 2014-09-30, per its 10-Q filed 2014-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingExpense · last filed 2014-11-14
- SKYSTAR BIO-PHARMACEUTICAL CO selling expense for the quarter ending 2014-09-30 was $1.08M, a 14.61% decline year-over-year.
- SKYSTAR BIO-PHARMACEUTICAL CO selling expense for the quarter ending 2014-06-30 was $834.61K, a 32.62% increase year-over-year.
- SKYSTAR BIO-PHARMACEUTICAL CO selling expense for the quarter ending 2014-03-31 was $370.21K, a 16.48% increase year-over-year.
- SKYSTAR BIO-PHARMACEUTICAL CO selling expense for the quarter ending 2013-12-31 was $1.34M, a 37.81% increase year-over-year.
- SKYSTAR BIO-PHARMACEUTICAL CO selling expense for fiscal 2013 was $3.55M, a 16.87% increase from fiscal 2012.
- SKYSTAR BIO-PHARMACEUTICAL CO selling expense for fiscal 2012 was $3.04M, a 25.16% decline from fiscal 2011.
- SKYSTAR BIO-PHARMACEUTICAL CO selling expense for fiscal 2011 was $4.06M, a 91.16% increase from fiscal 2010.
- SKYSTAR BIO-PHARMACEUTICAL CO selling expense for fiscal 2010 was $2.12M.
| Period end | Selling Expense 3 month | Selling Expense 6 month | Selling Expense 9 month | Selling Expense 12 month |
|---|---|---|---|---|
| 2014-09-30 | $1.08M 10-Q · filed 2014-11-14 | $1.92M derived: sum of 2 quarters · filed 2014-11-14 | $2.29M 10-Q · filed 2014-11-14 | $3.63M derived: sum of 4 quarters · filed 2014-11-14 |
| 2014-06-30 | $834.61K 10-Q · filed 2014-08-14 | $1.20M 10-Q · filed 2014-08-14 | $2.54M derived: sum of 3 quarters · filed 2014-08-14 | $3.81M derived: sum of 4 quarters · filed 2014-11-14 |
| 2014-03-31 | $370.21K 10-Q · filed 2014-05-15 | $1.71M derived: sum of 2 quarters · filed 2014-05-15 | $2.98M derived: sum of 3 quarters · filed 2014-11-14 | $3.61M derived: sum of 4 quarters · filed 2014-11-14 |
| 2013-12-31 | $1.34M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $2.61M derived: sum of 2 quarters · filed 2014-11-14 | $3.24M derived: sum of 3 quarters · filed 2014-11-14 | $3.55M 10-K · filed 2014-03-31 |
| 2013-09-30 | $1.27M 10-Q · filed 2014-11-14 | $1.90M derived: sum of 2 quarters · filed 2014-11-14 | $2.21M 10-Q · filed 2014-11-14 | $3.19M derived: sum of 4 quarters · filed 2014-11-14 |
| 2013-06-30 | $629.34K 10-Q · filed 2014-08-14 | $947.17K 10-Q · filed 2014-08-14 | $1.92M derived: sum of 3 quarters · filed 2014-08-14 | $2.61M derived: sum of 4 quarters · filed 2014-08-14 |
| 2013-03-31 | $317.84K 10-Q · filed 2014-05-15 | $1.29M derived: sum of 2 quarters · filed 2014-05-15 | $1.98M derived: sum of 3 quarters · filed 2014-05-15 | $2.65M derived: sum of 4 quarters · filed 2014-05-15 |
| 2012-12-31 | $971.84K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $1.66M derived: sum of 2 quarters · filed 2014-03-31 | $2.33M derived: sum of 3 quarters · filed 2014-03-31 | $3.04M 10-K · filed 2014-03-31 |
| 2012-09-30 | $692.01K 10-Q · filed 2013-11-14 | $1.36M derived: sum of 2 quarters · filed 2013-11-14 | $2.07M 10-Q · filed 2013-11-14 | $3.98M derived: sum of 4 quarters · filed 2013-11-14 |
| 2012-06-30 | $670.57K 10-Q · filed 2013-08-14 | $1.38M 10-Q · filed 2013-08-14 | $3.28M derived: sum of 3 quarters · filed 2013-08-14 | $4.46M derived: sum of 4 quarters · filed 2013-08-14 |
| 2012-03-31 | $705.62K 10-Q · filed 2013-05-15 | $2.61M derived: sum of 2 quarters · filed 2013-05-15 | $3.79M derived: sum of 3 quarters · filed 2013-05-15 | $4.40M derived: sum of 4 quarters · filed 2013-05-15 |
| 2011-12-31 | $1.91M derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-01 | $3.08M derived: sum of 2 quarters · filed 2013-04-01 | $3.69M derived: sum of 3 quarters · filed 2013-04-01 | $4.06M 10-K · filed 2013-04-01 |
| 2011-09-30 | $1.17M 10-Q · filed 2012-11-14 | $1.78M derived: sum of 2 quarters · filed 2012-11-14 | $2.15M 10-Q · filed 2012-11-14 | $2.97M derived: sum of 4 quarters · filed 2012-11-14 |
| 2011-06-30 | $609.83K 10-Q/A · filed 2012-09-13 | $979.23K 10-Q/A · filed 2012-09-13 | $1.79M derived: sum of 3 quarters · filed 2012-09-13 | $2.50M derived: sum of 4 quarters · filed 2012-09-13 |
| 2011-03-31 | $369.40K 10-Q · filed 2012-05-15 | $1.18M derived: sum of 2 quarters · filed 2012-05-15 | $1.89M derived: sum of 3 quarters · filed 2012-05-15 | $2.32M derived: sum of 4 quarters · filed 2012-05-15 |
| 2010-12-31 | $812.82K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $1.52M derived: sum of 2 quarters · filed 2012-03-30 | $1.95M derived: sum of 3 quarters · filed 2012-03-30 | $2.12M 10-K · filed 2012-03-30 |
| 2010-09-30 | $709.19K 10-Q · filed 2011-11-14 | $1.14M derived: sum of 2 quarters · filed 2011-11-14 | $1.31M 10-Q · filed 2011-11-14 | |
| 2010-06-30 | $431.81K 10-Q/A · filed 2011-09-21 | $602.94K 10-Q/A · filed 2011-09-21 |